MENU

ORGS

Stock ticker:

PRICE

CHANGE

CAPITALIZATION

Orgenesis (ORGS) Ownership - Who owns Orgenesis?

Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

N/A

Phone

N/A

Employees

N/A

Web

N/A

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

457.64K

P/E Ratio

N/A

Total Cash

204K

Projected Growth

N/A

Total Debt

17.3M

Revenue

899K

Risk (Beta)

0.88

Dividend Yield

N/A

Total Cash/Share

0.02

Total Debt/Equity

N/A

Revenue/Share

0.25 USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ORGS

A.I. Advisor

published General Information

General Information

a development stage company, which focuses on treatment of diabetes

Industry Biotechnology

Profile

Details

Industry

Biotechnology

Address

N/A

Phone

N/A

Employees

N/A

Web

N/A